[1] [2] Despite marketing claims found online, there is no substantial clinical evidence supporting BPC-157's safety or efficacy in humans
Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity
It keeps the injection volume manageable
It's incredibly difficult to "overdose" on B12 because your body efficiently removes what it doesn't use
The duration of use varies, but many follow a 2- to 4-week cycle for acute injuries, while chronic conditions may require longer use
Imbalance in mitochondrial fission and fusion is a key trigger for Parkinsons disease, and defects in mitochondrial dynamics limit mitochondrial movement, leading to a reduction in ATP, excessive oxidative stress, and mtDNA deficiency, which ultimately leads to cell death (Geng et al., 2019)